This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.A Jemal , R Siegel , E Ward , Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71–96.
2.SG Diab , RM Elledge , GM Clark . Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000; 92: 550–556.
3.K Holli , J Isola . Effect of age on the survival of breast cancer patients. Eur J Cancer 1997; 33: 425–428.
4.I Jatoi , BE Chen , WF Anderson , PS Rosenberg . Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 2007; 25: 1683–1690.
5.Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687–1717.
6.WB Sateren , EL Trimble , J Abrams , How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002; 20: 2109–2117.
7.LF Hutchins , JM Unger , JJ Crowley , CA Jr Coltman , KS Albain . Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341: 2061–2067.
8.HB Muss , S Woolf , D Berry , Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005; 293: 1073–1081.
9.SH Giordano , Z Duan , YF Kuo , GN Hortobagyi , JS Goodwin . Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 2006; 24: 2750–2756.
10.HB Muss , DA Berry , C Cirrincione , Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience. J Clin Oncol 2007; 25: 3699–3704.
11.MC Pinder , Z Duan , JS Goodwin , GN Hortobagyi , SH Giordano . Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 2007; 25: 3808–3815.
12.DA Patt , Z Duan , S Fang , GN Hortobagyi , SH Giordano . Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk. J Clin Oncol 2007; 25: 3871–3876.
15.CM Perou , T Sorlie , MB Eisen , Molecular portraits of human breast tumours. Nature 2000; 406: 747–752.
16.S Paik , S Shak , G Tang , A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004; 351: 2817–2826.
17.S Paik , G Tang , S Shak , Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006; 24: 3726–3734.
18.EH Romond , EA Perez , J Bryant , Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005; 353: 1673–1684.
19.MJ Piccart-Gebhart , M Procter , B Leyland-Jones , Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005; 353: 1659–1672.
20.EA Perez , VJ Suman , NE Davidson , Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol 2008; 26: 1231–1238.
21.ML Telli , SA Hunt , RW Carlson , AE Guardino . Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol 2007; 25: 3525–3533.
22.D Slamon , W Eiermann , N Robert , Second interim analysis phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab with docetaxel, carboplatin and trastuzumab in Her2neu postiive early breast cancer patients [Abstract]. Breast Cancer Res Treat 2006.
23.SE Jones , MA Savin , FA Holmes , Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. J Clin Oncol 2006; 24: 5381–5387.
24.DA Berry , C Cirrincione , IC Henderson , Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 2006; 295: 1658–1667.
25.DF Hayes , AD Thor , LG Dressler , HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med 2007; 357: 1496–1506.
27.EB Elkin , A Hurria , N Mitra , D Schrag , KS Panageas . Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol 2006; 24: 2757–2764.
29.MM Kemeny , BL Peterson , AB Kornblith , Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 2003; 21: 2268–2275.
30.D Saliba , M Elliott , LZ Rubenstein , The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001; 49: 1691–1699.
31.A Hurria , S Gupta , M Zauderer , Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 2005; 104: 1998–2005.
32.MB Rodin , SG Mohile . A practical approach to geriatric assessment in oncology. J Clin Oncol 2007; 25: 1936–1944.
34.H Wildiers , I Kunkler , L Biganzoli , Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007; 8: 1101–1115.
35.D Crivellari , M Aapro , R Leonard , Breast cancer in the elderly. J Clin Oncol 2007; 25: 1882–1890.
36.L Biganzoli , M Aapro , L Balducci , D Crivellari , A Minisini , M Piccart . Adjuvant therapy in elderly patients with breast cancer. Clin Breast Cancer 2004; 5: 188–195.